Full Text Journal Articles by
Author Trinity Bivalacqua

Advertisement

Find full text journal articles






Four versus Three Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Implications for Pathologic Response and Survival.

Hiten D Patel, Sunil H Patel, Enrique Blanco-Martinez, Jake Kuzbel, Victor S Chen, Aleksander Druck, Elizabeth L Koehne, Parth M Patel, Chirag P Doshi, Noah M Hahn, Jean H Hoffman-Censits, Stephanie Berg, Trinity J Bivalacqua, Max Kates, Marcus L Quek,

<h4>Purpose</h4>Ideal number of neoadjuvant chemotherapy (NAC) cycles for muscle-invasive bladder cancer is uncertain with 3 to 4 representing the standard of care (SOC). We compared ypT0 rates and survival between patients receiving 4 versus 3 cycles of NAC with evaluation of chemotherapy-related toxicity for correlation with tumor chemosensitivity and pathologic ... Read more >>

J Urol (The Journal of urology)
[2021, :101097JU0000000000002189]

Cited: 0 times

View full text PDF listing >>



Acute Ischemic Priapism: An AUA/SMSNA Guideline.

Trinity J Bivalacqua, Bryant K Allen, Gerald Brock, Gregory A Broderick, Tobias S Kohler, John P Mulhall, Jeff Oristaglio, Leila L Rahimi, Zora R Rogers, Ryan P Terlecki, Landon Trost, Faysal A Yafi, Nelson E Bennett,

<h4>Purpose</h4>Priapism is a persistent penile erection that continues hours beyond, or is unrelated to, sexual stimulation and results in a prolonged and uncontrolled erection. Given its time-dependent and progressive nature, priapism is a situation that both urologists and emergency medicine practitioners must be familiar with and comfortable managing. Acute ischemic ... Read more >>

J Urol (The Journal of urology)
[2021, :101097JU0000000000002236]

Cited: 0 times

View full text PDF listing >>



Advertisement

Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes.

Jean H Hoffman-Censits, Kara A Lombardo, Vamsi Parimi, Sonia Kamanda, Woonyoung Choi, Noah M Hahn, David J McConkey, Bridget M McGuire, Trinity J Bivalacqua, Max Kates, Andres Matoso,

The antibody-drug conjugate enfortumab-vedotin acts by targeting nectin-4, a protein that is nearly ubiquitously expressed in conventional urothelial cancer. However, expression of nectin-4 in morphologic variants of urothelial carcinoma and nonurothelial histotypes was unknown. Immunohistochemistry for nectin-4 using was performed on 169 patients including 83 with nonmuscle invasive bladder cancer ... Read more >>

Appl Immunohistochem Mol Morphol (Applied immunohistochemistry & molecular morphology : AIMM)
[2021, 29(8):619-625]

Cited: 0 times

View full text PDF listing >>



Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer.

David D'Andrea, Peter C Black, Homayoun Zargar, Colin P Dinney, Francesco Soria, Michael S Cookson, Jeffrey S Montgomery, Wassim Kassouf, Marc A Dall'Era, Srikala S Sridhar, John S McGrath, Jonathan L Wright, Andrew C Thorpe, Jeff M Holzbeierlein, Diego M Carrión, Ettore Di Trapani, Trinity J Bivalacqua, Scott North, Daniel A Barocas, Yair Lotan, Petros Grivas, Andrew J Stephenson, Bas W van Rhijn, Siamak Daneshmand, Philippe E Spiess, Shahrokh F Shariat,

<h4>Purpose</h4>We investigated the pathological response rates and survival associated with 3 vs 4 cycles of cisplatin-based neoadjuvant chemotherapy (NAC) in patients with cT2-4N0M0 muscle invasive bladder cancer.<h4>Materials and methods</h4>In this cohort study we analyzed clinical data of 828 patients treated with NAC and radical cystectomy between 2000 and 2020. A ... Read more >>

J Urol (The Journal of urology)
[2021, :101097JU0000000000002190]

Cited: 0 times

View full text PDF listing >>



Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.

David D'Andrea, Peter C Black, Homayoun Zargar, Kamran Zargar-Shoshtari, Francesco Soria, Adrian S Fairey, Laura S Mertens, Colin P Dinney, Maria C Mir, Laura-Maria Krabbe, Michael S Cookson, Niels-Erik Jacobsen, Jeffrey S Montgomery, Nikhil Vasdev, Evan Y Yu, Evanguelos Xylinas, Nicholas J Campain, Wassim Kassouf, Marc A Dall'Era, Jo-An Seah, Cesar E Ercole, Simon Horenblas, Srikala S Sridhar, John S McGrath, Jonathan Aning, Jonathan L Wright, Andrew C Thorpe, Todd M Morgan, Jeff M Holzbeierlein, Trinity J Bivalacqua, Scott North, Daniel A Barocas, Yair Lotan, Petros Grivas, Andrew J Stephenson, Jay B Shah, Bas W van Rhijn, Siamak Daneshmand, Philippe E Spiess, Shahrokh F Shariat,

<h4>Purpose</h4>To assess the association of patient age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer (MIBC).<h4>Materials and methods</h4>We analyzed data from 1105 patients with MIBC. Patients age was evaluated as continuous variable and stratified in quartiles. Pathologic objective response (pOR; ypT0-Ta-Tis-T1N0) and pathologic complete response (pCR; ypT0N0), ... Read more >>

World J Urol (World journal of urology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Increased Level of Tumor Necrosis Factor-Alpha (TNF-α) Leads to Downregulation of Nitrergic Neurons Following Bilateral Cavernous Nerve Injury and Modulates Penile Smooth Tone.

Hotaka Matsui, Nikolai A Sopko, Jeffrey D Campbell, Xiaopu Liu, Allison Reinhardt, Emmanuel Weyne, Fabio Castiglione, Maarten Albersen, Johanna L Hannan, Trinity J Bivalacqua,

<h4>Background</h4>Erectile dysfunction (ED) after injury to peripheral cavernous nerve (CN) is partly a result of inflammation in pelvic ganglia, suggesting that ED may be prevented by inhibiting neuroinflammation.<h4>Aim</h4>The aim of this study is to examine temporal changes of TNF-α, after bilateral CN injury (BCNI), to evaluate effect of exogenous TNF-α ... Read more >>

J Sex Med (The journal of sexual medicine)
[2021, 18(7):1181-1190]

Cited: 0 times

View full text PDF listing >>



The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers.

Eva Compérat, Mahul B Amin, Jonathan I Epstein, Donna E Hansel, Gladell Paner, Hikmat Al-Ahmadie, Larry True, Dilek Bayder, Trinity Bivalacqua, Fadi Brimo, Liang Cheng, John Cheville, Guido Dalbagni, Sara Falzarano, Jennifer Gordetsky, Charles Guo, Sounak Gupta, Ondrej Hes, Gopa Iyer, Seema Kaushal, Lakshmi Kunju, Cristina Magi-Galluzzi, Andres Matoso, Jesse McKenney, George J Netto, Adeboye O Osunkoya, Chin Chen Pan, Kristina Pivovarcikova, Maria R Raspollini, Henning Reis, Jonathan Rosenberg, Morgan Roupret, Rajal B Shah, Shahrokh F Shariat, Kiril Trpkov, Veronika Weyerer, Ming Zhou, Victor Reuter,

The Genitourinary Pathology Society (GUPS) undertook a critical review of the recent advances in bladder cancer focusing on important topics of high interest for the practicing surgical pathologist and urologist. This review represents the second of 2 manuscripts ensuing from this effort. Herein, we address the effective reporting of bladder ... Read more >>

Adv Anat Pathol (Advances in anatomic pathology)
[2021, 28(4):196-208]

Cited: 0 times

View full text PDF listing >>



The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia.

Mahul B Amin, Eva Comperat, Jonathan I Epstein, Lawrence D True, Donna Hansel, Gladell P Paner, Hikmat Al-Ahmadie, Dilek Baydar, Trinity Bivalacqua, Fadi Brimo, Liang Cheng, John Cheville, Guido Dalbagni, Sara Falzarano, Jennifer Gordetsky, Charles C Guo, Sounak Gupta, Ondra Hes, Gopa Iyer, Seema Kaushal, Lakshmi Kunju, Cristina Magi-Galluzzi, Andres Matoso, George Netto, Adeboye O Osunkoya, Chin Chen Pan, Kristina Pivovarcikova, Maria R Raspollini, Henning Reis, Jonathan Rosenberg, Morgan Roupret, Rajal B Shah, Shahrokh Shariat, Kiril Trpkov, Veronika Weyerer, Ming Zhou, Jesse McKenney, Victor E Reuter,

The Genitourinary Pathology Society (GUPS) undertook a critical review of the recent advances in bladder neoplasia with a focus on issues relevant to the practicing surgical pathologist for the understanding and effective reporting of bladder cancer, emphasizing particularly on the newly accumulated evidence post-2016 World Health Organization (WHO) classification. The ... Read more >>

Adv Anat Pathol (Advances in anatomic pathology)
[2021, 28(4):179-195]

Cited: 0 times

View full text PDF listing >>



100 years of Bacillus Calmette-Guérin immunotherapy: from cattle to COVID-19.

Niyati Lobo, Nathan A Brooks, Alexandre R Zlotta, Jeffrey D Cirillo, Stephen Boorjian, Peter C Black, Joshua J Meeks, Trinity J Bivalacqua, Paolo Gontero, Gary D Steinberg, David McConkey, Marko Babjuk, J Alfred Witjes, Ashish M Kamat,

Bacillus Calmette-Guérin (BCG) is the most widely used vaccine worldwide and has been used to prevent tuberculosis for a century. BCG also stimulates an anti-tumour immune response, which urologists have harnessed for the treatment of non-muscle-invasive bladder cancer. A growing body of evidence indicates that BCG offers protection against various ... Read more >>

Nat Rev Urol (Nature reviews. Urology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCG.

Ryan L Steinberg, Vignesh T Packiam, Lewis J Thomas, Nathan Brooks, Andrew Vitale, Sarah L Mott, Trafford Crump, Jonathan Wang, William C DeWolf, Donald L Lamm, Max Kates, M Eric Hyndman, Ashish M Kamat, Trinity J Bivalacqua, Kenneth G Nepple, Michael A O'Donnell,

<h4>Introduction</h4>Repeat BCG induction remains an option for select non-muscle invasive bladder cancer (NMIBC) patients who fail initial therapy. Alternative salvage intravesical regimens such as Gemcitabine and Docetaxel (Gem/Doce) have been investigated. We aimed to compare the efficacy BCG plus interferon a-2b (BCG/IFN) and Gem/Doce in patients with recurrent NMIBC after ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study.

Beat Foerster, Mohammad Abufaraj, Surena F Matin, Mounsif Azizi, Mohit Gupta, Wei-Ming Li, Thomas Seisen, Timothy Clinton, Evanguelos Xylinas, M Carmen Mir, Donald Schweitzer, Andrea Mari, Shoji Kimura, Marco Bandini, Romain Mathieu, Ja H Ku, Gautier Marcq, Georgi Guruli, Markus Grabbert, Anna K Czech, Tim Muilwijk, Armin Pycha, David D'Andrea, Firas G Petros, Philippe E Spiess, Trinity Bivalacqua, Wen-Jeng Wu, Morgan Rouprêt, Laura-Maria Krabbe, Kees Hendricksen, Shin Egawa, Alberto Briganti, Marco Moschini, Vivien Graffeille, Wassim Kassouf, Riccardo Autorino, Axel Heidenreich, Piotr Chlosta, Steven Joniau, Francesco Soria, Phillip M Pierorazio, Shahrokh F Shariat,

<h4>Background</h4>Several groups have proposed features to identify low-risk patients who may benefit from endoscopic kidney-sparing surgery in upper tract urothelial carcinoma (UTUC).<h4>Objective</h4>To evaluate standard risk stratification features, develop an optimal model to identify ≥pT2/N+ stage at radical nephroureterectomy (RNU), and compare it with the existing unvalidated models.<h4>Design, setting, and participants</h4>This ... Read more >>

Eur Urol (European urology)
[2021, 80(4):507-515]

Cited: 0 times

View full text PDF listing >>



Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA).

James L Liu, Kevin Y Chu, Andrew T Gabrielson, Run Wang, Landon Trost, Gregory Broderick, Kelvin Davies, Gerald Brock, John Mulhall, Ranjith Ramasamy, Trinity J Bivalacqua,

<h4>Introduction</h4>Current non-invasive treatments for erectile dysfunction (ED) include oral medications, intracavernosal injections, and vacuum-assisted devices. Though these therapies work well for many, a subset of patients have contraindications or are unsatisfied with these options. Restorative therapies for ED are a new frontier of treatments focused on regenerating diseased tissue and ... Read more >>

Sex Med (Sexual medicine)
[2021, 9(3):100343]

Cited: 0 times

View full text PDF listing >>



Single-cell Transcriptomics Uncover a Novel Role of Myeloid Cells and T-lymphocytes in the Fibrotic Microenvironment in Peyronie's Disease.

Uros Milenkovic, Bram Boeckx, Diether Lambrechts, Rekin's Janky, Georgios Hatzichristodoulou, Koen van Renterghem, Thomas Gevaert, Selim Cellek, Trinity J Bivalacqua, Dirk De Ridder, Maarten Albersen,

<h4>Background</h4>Peyronie's disease (PD) is an acquired fibrotic disease affecting the penile tunica albuginea that can lead to curvature and deformities, shortening, and erectile dysfunction. Although immunological mechanisms have been suggested for the pathophysiology of PD, these have not been investigated using single-cell transcriptomics.<h4>Objective</h4>To investigate the immunological signature of plaques from ... Read more >>

Eur Urol Focus (European urology focus)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study.

Gautier Marcq, Beat Foerster, Mohammad Abufaraj, Surena F Matin, Mounsif Azizi, Mohit Gupta, Wei-Ming Li, Thomas Seisen, Timothy Clinton, Evanguelos Xylinas, M Carmen Mir, Donald Schweitzer, Andrea Mari, Shoji Kimura, Marco Bandini, Romain Mathieu, Ja H Ku, Georgi Guruli, Markus Grabbert, Anna K Czech, Tim Muilwijk, Armin Pycha, David D'Andrea, Firas G Petros, Philippe E Spiess, Trinity Bivalacqua, Wen-Jeng Wu, Morgan Rouprêt, Laura-Maria Krabbe, Kees Hendricksen, Shin Egawa, Alberto Briganti, Marco Moschini, Vivien Graffeille, Riccardo Autorino, Patricia John, Axel Heidenreich, Piotr Chlosta, Steven Joniau, Francesco Soria, Phillip M Pierorazio, Shahrokh F Shariat, Wassim Kassouf,

<h4>Background</h4>The European Association of Urology risk stratification dichotomizes patients with upper tract urothelial carcinoma (UTUC) into two risk categories.<h4>Objective</h4>To evaluate the predictive value of a new classification to better risk stratify patients eligible for kidney-sparing surgery (KSS).<h4>Design, setting, and participants</h4>This was a retrospective study including 1214 patients from 21 centers ... Read more >>

Eur Urol Focus (European urology focus)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Surgical challenges and considerations in Tri-modal therapy for muscle invasive bladder cancer.

Adam S Feldman, Girish S Kulkarni, Trinity J Bivalacqua, Peter C Black, Scott Delacroix, Seth P Lerner, Ashish M Kamat, Wassim Kassouf,

Trimodal therapy (TMT) for muscle invasive bladder cancer has become an accepted alternative to radical cystectomy and has become integrated into national guidelines as standard a treatment option. The urologist plays a critical role in proper patient selection, thorough transurethral resection, ongoing cystoscopic surveillance and management of local recurrences. There ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Urothelial Carcinoma In Situ of the Bladder: Correlation of CK20 Expression With Adaptive Immune Resistance, Response to BCG Therapy, and Clinical Outcome.

Kara A Lombardo, Belkiss Murati Amador, Vamsi Parimi, Jean Hoffman-Censits, Woonyoung Choi, Noah M Hahn, Max Kates, Trinity J Bivalacqua, David McConkey, Mohammad O Hoque, Andres Matoso,

Immunohistochemical stains have been suggested to aid in diagnostically challenging cases of urothelial carcinoma in-situ (CIS). Although full thickness immunostaining for CK20 is supportive of CIS, a subset of CIS cases is CK20(-), the clinical significance of which was unknown. This study included 43 patients with primary diagnosis of bladder ... Read more >>

Appl Immunohistochem Mol Morphol (Applied immunohistochemistry & molecular morphology : AIMM)
[2021, 29(2):127-135]

Cited: 0 times

View full text PDF listing >>



Reply by Authors.

Thomas G W Harris, Roni Manyevitch, Wayland J Wu, Angelo A Leto Barone, Trinity J Bivalacqua, Arthur L Burnett, John P Gearhart, Richard J Redett,

J Urol (The Journal of urology)
[2021, 205(3):887]

Cited: 0 times

View full text PDF listing >>



Contemporary Assessment of the Most Cited Clinical, Basic Science, and Guidelines Papers in Urology: A Reference for Urology Journal Club.

Andrew T Gabrielson, Mitchell M Huang, Kelly T Harris, Zeyad R Schwen, Alan W Partin, Trinity J Bivalacqua,

<h4>Objective</h4>To perform bibliometric analysis of the top cited articles in urology as a guide for journal club article selection.<h4>Methods</h4>Bibliometric citation analysis was performed using Scopus. Tables illustrating the top cited clinical, basic science, and guidelines/position statements papers were constructed. Linear regression was used to determine association between h-index and number ... Read more >>

Urology (Urology)
[2021, 149:58-69]

Cited: 0 times

View full text PDF listing >>



Preclinical evaluation of a hypotonic docetaxel nanosuspension formulation for intravesical treatment of non-muscle-invasive bladder cancer.

Abhijit A Date, Max Kates, Takahiro Yoshida, Taarika Babu, Umara Afzal, Pranjali Kanvinde, Alexander Baras, Nicole Anders, Ping He, Michelle Rudek, Justin Hanes, Trinity J Bivalacqua, Laura M Ensign,

Intravesical chemotherapy is a key approach for treating refractory non-muscle-invasive bladder cancer (NMIBC). However, the effectiveness of intravesical chemotherapy is limited by bladder tissue penetration and retention. Here, we describe the development of a docetaxel nanosuspension that, when paired with a low osmolality (hypotonic) vehicle, demonstrates increased uptake by the ... Read more >>

Drug Deliv Transl Res (Drug delivery and translational research)
[2021, 11(5):2085-2095]

Cited: 0 times

View full text PDF listing >>



Plastic exposure and urological malignancies - an emerging field.

Sunil H Patel, Meredith Metcalf, Trinity J Bivalacqua, Max Kates,

Nat Rev Urol (Nature reviews. Urology)
[2020, 17(12):653-654]

Cited: 0 times

View full text PDF listing >>



Predictors of local recurrence and its impact on survival after glansectomy for penile cancer: time to challenge the dogma?

Eduard Roussel, Eline Peeters, Joren Vanthoor, Giorgio Bozzini, Asif Muneer, Ben Ayres, Denosshan Sri, Nick Watkin, Rohit Bhattar, Arie Parnham, Vijay Sangar, Maurice Lau, Gregory Joice, Trinity J Bivalacqua, Juan Chipollini, Philippe E Spiess, Georgios Hatzichristodoulou, Lieke de Vries, Oscar Brouwer, Maarten Albersen, ,

<h4>Objectives</h4>To identify predictive pathological factors for local recurrence (LR) and to study the impact of LR on survival in patients treated with glansectomy for penile squamous cell carcinoma (pSCC).<h4>Patients and methods</h4>We retrospectively studied patients treated with glansectomy at international, high-volume reference centres. We analysed histopathological predictors of LR, stratified patients ... Read more >>

BJU Int (BJU international)
[2021, 127(5):606-613]

Cited: 1 time

View full text PDF listing >>



Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis.

Francesco Soria, Peter C Black, Adrian S Fairey, Michael S Cookson, Evan Y Yu, Wassim Kassouf, Marc A Dall'Era, Srikala S Sridhar, John S McGrath, Jonathan L Wright, Andrew C Thorpe, Todd M Morgan, Siamak Daneshmand, Jeff M Holzbeierlein, Trinity J Bivalacqua, Scott North, Daniel A Barocas, Yair Lotan, Petros Grivas, Andrew J Stephenson, Jay B Shah, Bas W van Rhijn, Philippe E Spiess, Shahrokh F Shariat, Paolo Gontero,

<h4>Objectives</h4>To assess the efficacy of neoadjuvant chemotherapy (NAC) before radical cystectomy (RC) in a retrospective multicentre cohort of patients with cT2N0M0 bladder cancer (BCa) without preoperative hydronephrosis.<h4>Patients and methods</h4>This was a propensity-based analysis of 619 patients. Of these, 316 were treated with NAC followed by RC and 303 with upfront ... Read more >>

BJU Int (BJU international)
[2021, 128(1):79-87]

Cited: 2 times

View full text PDF listing >>



Reply to Gopa Iyer, Bernard H. Bochner, Eliezer M. Van Allen, David B. Solit, and Jonathan E. Rosenberg's Letter to the Editor re: Russell E.N. Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016.

Russell E N Becker, Alex Baras, Trinity J Bivalacqua,

Eur Urol (European urology)
[2021, 79(2):e58-e59]

Cited: 0 times

View full text PDF listing >>



Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience.

Jean Hoffman-Censits, Woonyoung Choi, Trinity J Bivalacqua, Philip Pierorazio, Max Kates, Kara Lombardo, Vamsi Parini, David McConkey, Edouard J Trabulsi, Noah Hahn, Andres Matoso,

Clin Genitourin Cancer (Clinical genitourinary cancer)
[2021, 19(2):176-181]

Cited: 0 times

View full text PDF listing >>



Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma.

Joseph G Cheaib, Lauren E Claus, Hiten D Patel, Max R Kates, Andres Matoso, Noah M Hahn, Trinity J Bivalacqua, Jean H Hoffman-Censits, Phillip M Pierorazio,

<h4>Purpose</h4>Metastatic recurrence occurs in over 25% of upper tract urothelial carcinoma patients treated with radical nephroureterectomy. While metastatic recurrence suggests poor prognosis, the impact of the specific site of recurrence on prognosis is not well documented.<h4>Materials and methods</h4>We retrospectively analyzed 188 patients who underwent radical nephroureterectomy for high-grade, node-negative upper ... Read more >>

Urol Oncol (Urologic oncology)
[2021, 39(1):74.e9-74.e16]

Cited: 0 times

View full text PDF listing >>



Advertisement


Disclaimer

1.1149 s